4//SEC Filing
Rosenberg Aaron 4
Accession 0001651308-25-000108
CIK 0001651308other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 5:45 PM ET
Size
7.7 KB
Accession
0001651308-25-000108
Insider Transaction Report
Form 4
Rosenberg Aaron
Chief Financial Officer
Transactions
- Award
Share Option (Right to Buy)
2025-06-10+119,873→ 119,873 totalExercise: $20.26Exp: 2035-06-09→ Ordinary Shares (119,873 underlying) - Award
Ordinary Shares
2025-06-10+63,674→ 230,802 total
Footnotes (3)
- [F1]Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
- [F2]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each American Depositary Share represents 13 ordinary shares.
- [F3]These securities vest over a four-year period as follows: 25% on the first anniversary of June 10, 2025 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
Documents
Issuer
BeOne Medicines Ltd.
CIK 0001651308
Entity typeother
Related Parties
1- filerCIK 0002031182
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 5:45 PM ET
- Size
- 7.7 KB